NovaBay Pharmaceuticals Inc (NBY.A)

NBY.A

About

NovaBay Pharmaceuticals, Inc. (NovaBay) is a biopharmaceutical company. The Company operates through four segments: dermatology, ophthalmology, urology and wound care. The dermatology segment includes NovaBay's business around the dermatology area, including the collaboration with Galderma and their impetigo clinical trial. The... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.69
Market Cap(Mil.):	$17.18
Shares Outstanding(Mil.):	85.94
Dividend:	--
Yield (%):	--

Financials

	NBY.A	Industry	Sector
P/E (TTM):	--	35.19	33.61
EPS (TTM):	-0.33	--	--
ROI:	-192.65	-1.28	14.75
ROE:	-257.92	0.88	15.96

Latest News about NBY.A

» More NBY.A News

Competitors

	Price	Chg
PuriCore plc (PURI.L)	19.50p	0.00
C R Bard Inc (BCR.N)	$181.99	-1.96
Smith & Nephew plc (SN.L)	1,074.00p	-6.00
Abbott Laboratories (ABT.N)	$44.19	-0.88
GlaxoSmithKline plc (GSK.L)	1,310.50p	-21.00
3M Co (MMM.N)	$156.30	-2.75
Sanofi SA (SASY.PA)	€81.19	-0.17
Pfizer Inc. (PFE.N)	$33.39	-0.35
Novartis AG (NOVN.VX)	CHF86.40	-1.15
Johnson & Johnson (JNJ.N)	$100.27	-1.59

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - NovaBay Pharmaceuticals Inc (NBY-A) Provider : Thomson Reuters Stock Report	$25.00 Buy
ValuEngine Rating and Forecast Report for NBY Provider : ValuEngine, Inc.	$25.00 Buy
Wright Investors Service Comprehensive Report for Novabay Pharmaceuticals, Inc. Provider : Wright Reports	$75.00 Buy
NOVABAY PHARMACEUTICALS INC (NBY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS Provider : Pechala's Reports	$25.00 Buy
NovaBay Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider : Reuters Investment Profile	$20.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

More from Reuters

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.